Abeer Alsarraj

1.3k total citations · 1 hit paper
25 papers, 889 citations indexed

About

Abeer Alsarraj is a scholar working on Surgery, Epidemiology and Hepatology. According to data from OpenAlex, Abeer Alsarraj has authored 25 papers receiving a total of 889 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Surgery, 10 papers in Epidemiology and 7 papers in Hepatology. Recurrent topics in Abeer Alsarraj's work include Liver Disease Diagnosis and Treatment (9 papers), Esophageal Cancer Research and Treatment (9 papers) and Helicobacter pylori-related gastroenterology studies (6 papers). Abeer Alsarraj is often cited by papers focused on Liver Disease Diagnosis and Treatment (9 papers), Esophageal Cancer Research and Treatment (9 papers) and Helicobacter pylori-related gastroenterology studies (6 papers). Abeer Alsarraj collaborates with scholars based in United States, Italy and Australia. Abeer Alsarraj's co-authors include Hashem B. El‐Serag, David Y. Graham, Jennifer R. Kramer, Fasiha Kanwal, Stephanie Fitzgerald, Nabihah Tayob, Rubén Hernáez, Rita Reddy, Seiji Shiota and Yasser H. Shaib and has published in prestigious journals such as Gastroenterology, PLoS ONE and Hepatology.

In The Last Decade

Abeer Alsarraj

25 papers receiving 865 citations

Hit Papers

The Performance of AFP, AFP-3, DCP as Biomarkers for Dete... 2022 2026 2023 2024 2022 40 80 120

Peers

Abeer Alsarraj
Christine Hachem United States
Elizabeth Coss United States
Rin Chang South Korea
Jin Hai Hyun South Korea
Hyoung Su Kim South Korea
Abeer Alsarraj
Citations per year, relative to Abeer Alsarraj Abeer Alsarraj (= 1×) peers Horng‐Yuan Wang

Countries citing papers authored by Abeer Alsarraj

Since Specialization
Citations

This map shows the geographic impact of Abeer Alsarraj's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abeer Alsarraj with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abeer Alsarraj more than expected).

Fields of papers citing papers by Abeer Alsarraj

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Abeer Alsarraj. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abeer Alsarraj. The network helps show where Abeer Alsarraj may publish in the future.

Co-authorship network of co-authors of Abeer Alsarraj

This figure shows the co-authorship network connecting the top 25 collaborators of Abeer Alsarraj. A scholar is included among the top collaborators of Abeer Alsarraj based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Abeer Alsarraj. Abeer Alsarraj is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Coarfa, Cristian, Sandra L. Grimm, Bing Yu, et al.. (2024). Differences in Prediagnostic Serum Metabolomic and Lipidomic Profiles Between Cirrhosis Patients with and without Incident Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma. Volume 11. 1699–1712. 2 indexed citations
2.
El‐Serag, Hashem B., Qingchun Jin, Nabihah Tayob, et al.. (2024). HES V2.0 outperforms GALAD for detection of HCC: A phase 3 biomarker study in the United States. Hepatology. 81(2). 465–475. 15 indexed citations
3.
Thrift, Aaron P., Fasiha Kanwal, Yanhong Liu, et al.. (2023). Risk stratification for hepatocellular cancer among patients with cirrhosis using a hepatic fat polygenic risk score. PLoS ONE. 18(2). e0282309–e0282309. 13 indexed citations
4.
El‐Serag, Hashem B., Nabihah Tayob, Qingchun Jin, et al.. (2023). Mo1129 PHASE 3 BIOMARKER STUDY FOR HCC SURVEILLANCE USING A NOVEL HES V2.0 ALGORITHM. A PROSPECTIVE COLLECTION WITH RETROSPECTIVE BLINDED EVALUATION. Gastroenterology. 164(6). S–767. 1 indexed citations
5.
Kanwal, Fasiha, Saira Khaderi, Amit G. Singal, et al.. (2023). Risk Stratification Model for Hepatocellular Cancer in Patients With Cirrhosis. Clinical Gastroenterology and Hepatology. 21(13). 3296–3304.e3. 10 indexed citations
6.
Tayob, Nabihah, Fasiha Kanwal, Abeer Alsarraj, Rubén Hernáez, & Hashem B. El‐Serag. (2022). The Performance of AFP, AFP-3, DCP as Biomarkers for Detection of Hepatocellular Carcinoma (HCC): A Phase 3 Biomarker Study in the United States. Clinical Gastroenterology and Hepatology. 21(2). 415–423.e4. 131 indexed citations breakdown →
7.
Kanwal, Fasiha, Saira Khaderi, Amit G. Singal, et al.. (2022). Risk factors for HCC in contemporary cohorts of patients with cirrhosis. Hepatology. 77(3). 997–1005. 77 indexed citations
8.
Shiota, Seiji, Rita Reddy, Abeer Alsarraj, Hashem B. El‐Serag, & David Y. Graham. (2015). Antibiotic Resistance of Helicobacter pylori Among Male United States Veterans. Clinical Gastroenterology and Hepatology. 13(9). 1616–1624. 121 indexed citations
9.
Fischbach, Lori, David Y. Graham, Jennifer R. Kramer, et al.. (2014). Association between Helicobacter pylori and Barrett's Esophagus: A Case–Control Study. The American Journal of Gastroenterology. 109(3). 357–368. 54 indexed citations
10.
Wenker, Theresa Nguyen, Mamoun Younes, Abeer Alsarraj, et al.. (2014). Esophageal COX-2 Expression Is Increased in Barrett’s Esophagus, Obesity, and Smoking. Digestive Diseases and Sciences. 60(1). 65–73. 9 indexed citations
11.
El‐Serag, Hashem B., Abeer Alsarraj, Peter Richardson, et al.. (2013). Hepatocellular Carcinoma Screening Practices in the Department of Veterans Affairs: Findings from a National Facility Survey. Digestive Diseases and Sciences. 58(11). 3117–3126. 20 indexed citations
12.
Thrift, Aaron P., Jennifer R. Kramer, Abeer Alsarraj, & Hashem B. El‐Serag. (2013). Fat Mass by Bioelectrical Impedance Analysis is not Associated With Increased Risk of Barrett Esophagus. Journal of Clinical Gastroenterology. 48(3). 218–223. 17 indexed citations
13.
Garcia, José M., Andres E. Splenser, Jennifer R. Kramer, et al.. (2013). Circulating Inflammatory Cytokines and Adipokines Are Associated With Increased Risk of Barrett's Esophagus: A Case–Control Study. Clinical Gastroenterology and Hepatology. 12(2). 229–238.e3. 60 indexed citations
14.
Jiao, Li, Jennifer R. Kramer, Massimo Rugge, et al.. (2013). Dietary intake of vegetables, folate, and antioxidants and the risk of Barrett’s esophagus. Cancer Causes & Control. 24(5). 1005–1014. 23 indexed citations
15.
Lin, Derek, Jennifer R. Kramer, David J. Ramsey, et al.. (2013). Oral Bisphosphonates and the Risk of Barrettʼs Esophagus: Case–Control Analysis of US Veterans. The American Journal of Gastroenterology. 108(10). 1576–1583. 13 indexed citations
16.
Kramer, Jennifer R., Lori Fischbach, Peter Richardson, et al.. (2012). Waist-to-Hip Ratio, but Not Body Mass Index, Is Associated With an Increased Risk of Barrett's Esophagus in White Men. Clinical Gastroenterology and Hepatology. 11(4). 373–381.e1. 72 indexed citations
17.
Nordenstedt, Helena, David Y. Graham, Jennifer R. Kramer, et al.. (2012). Helicobacter pylori -Negative Gastritis: Prevalence and Risk Factors. The American Journal of Gastroenterology. 108(1). 65–71. 74 indexed citations
18.
Jiao, Li, Liang Chen, Abeer Alsarraj, et al.. (2012). Plasma soluble receptor for advanced glycation end-products and risk of colorectal adenoma.. PubMed. 3(4). 294–304. 14 indexed citations
19.
Thakkar, Kalpesh, et al.. (2011). Prevalence of Colorectal Polyps in Pediatric Colonoscopy. Digestive Diseases and Sciences. 57(4). 1050–1055. 49 indexed citations
20.
Thakkar, Kalpesh, et al.. (2010). M1575: The Frequency and Determinants of Polyps in Children: Results From a National Endoscopic Database. Gastrointestinal Endoscopy. 71(5). AB258–AB258. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026